Paula Soteropoulos insider trades: Dianthus Therapeutics (DNTH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paula reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | DNTH | ↓ Sell | 599 | $85.47 | $51K | Direct | May 11, 2026 (3d) |
| Mar 31, 2026 | DNTH | ↓ Sell | 599 | $80.11 | $48K | Direct | Apr 1, 2026 (1d) |
| Jun 13, 2024 | QURE | ↓ Sell | 2,220 | $5.14 | $11K | Direct | Jun 17, 2024 (4d) |
| Jun 16, 2023 | QURE | ↓ Sell | 2,275 | $18.99 | $43K | Direct | Jun 20, 2023 (4d) |
| Feb 27, 2023 | QURE | ↓ Sell | 384 | $19.97 | $8K | Direct | Mar 1, 2023 (2d) |
| Jan 18, 2023 | QURE | ↓ Sell | 6,000 | $22.59 | $136K | Direct | Jan 20, 2023 (2d) |
| Dec 14, 2022 | QURE | ↓ Sell | 6,800 | $23.44 | $159K | Direct | Dec 15, 2022 (1d) |
| Nov 29, 2022 | QURE | ↓ Sell | 6,200 | $25.38 | $157K | Direct | Dec 1, 2022 (2d) |
| Feb 28, 2022 | QURE | ↓ Sell | 596 | $16.87 | $10K | Direct | Mar 2, 2022 (2d) |
| Mar 2, 2021 | QURE | ↓ Sell | 504 | $37.60 | $19K | Direct | Mar 4, 2021 (2d) |
| Feb 5, 2020 | QURE | ↓ Sell | 2,122 | $60.95 | $129K | Direct | Feb 5, 2020 (0d) |
| Jan 28, 2020 | QURE | ↓ Sell | 807 | $62.19 | $50K | Direct | Jan 30, 2020 (2d) |
| Jan 7, 2020 | QURE | ↓ Sell | 3,000 | $72.18 | $217K | Direct | Jan 8, 2020 (1d) |
| Dec 13, 2019 | QURE | ↓ Sell | 2,000 | $70.50 | $141K | Direct | Dec 17, 2019 (4d) |
| Dec 9, 2019 | QURE | ↓ Sell | 11,582 | $64.96 | $752K | Direct | Dec 9, 2019 (0d) |
| Apr 8, 2019 | AKCA | ↓ Sell | 31,787 | $32.11 | $1.0M | Direct | Apr 9, 2019 (1d) |
| Mar 6, 2019 | AKCA | ↓ Sell | 18,386 | $32.14 | $591K | Direct | Mar 7, 2019 (1d) |
| Jan 28, 2019 | QURE | ↓ Sell | 1,210 | $31.32 | $38K | Direct | Jan 30, 2019 (2d) |
| Jan 29, 2018 | QURE | ↓ Sell | 2,878 | $18.53 | $53K | Direct | Jan 31, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DNTH insiders
Open-market trades in the last 12 months
About Paula Soteropoulos's insider trades
Paula Soteropoulos is an insider at Dianthus Therapeutics (DNTH). Since Jan 29, 2018, Paula has reported no open-market purchases and 19 sales worth $3.6M on SEC Form 4. In the last 12 months: 2 sales ($99K).
Their filings also include grants and awards (19 filings), option exercises (10 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.